Similar articles

• Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease.

  Beppu T, Ono Y, Matsui T, Hirai F, Yano Y, Takatsu N, Ninomiya K, Tsurumi K, Sato Y, Takahashi H, Ookado Y, Koga A, Kinjo K, Nagahama T, Hisabe T, Takaki Y, Yao K. Beppu T, et al. Dig Endosc. 2015 Jan;27(1):73-81. doi: 10.1111/den.12313. Epub 2014 Jul 17. Dig Endosc. 2015. PMID: 24833527
• Visceral Fat Is Associated With Mucosal Healing of Infliximab Treatment in Crohn's Disease.

  Shen W, Cao L, Li Y, Cai X, Ge Y, Zhu W. Shen W, et al. Dis Colon Rectum. 2018 Jun;61(6):706-712. doi: 10.1097/DCR.0000000000001074. Dis Colon Rectum. 2018. PMID: 29722729
• Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.

  Rutgeerts P, Diamond RH, Bala M, Olson A, Lichtenstein GR, Bao W, Patel K, Wolf DC, Safdi M, Colombel JF, Lashner B, Hanauer SB. Rutgeerts P, et al. Gastrointest Endosc. 2006 Mar;63(3):433-42; quiz 464. doi: 10.1016/j.gie.2005.08.011. Gastrointest Endosc. 2006. PMID: 16500392 Clinical Trial.
• Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us?

  Flynn A, Kane S. Flynn A, et al. Curr Opin Gastroenterol. 2011 Jul;27(4):342-5. doi: 10.1097/MOG.0b013e3283455c8f. Curr Opin Gastroenterol. 2011. PMID: 21378560 Review.
• Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

  Magro F, Portela F. Magro F, et al. BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. BioDrugs. 2010. PMID: 21175228 Review.